China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

CBPO 115.42 +1.98 (1.75%)
price chart
China Biologic Products Inc Bearish Signal Wp X Biologics Llc decreased Stake
Wp X Biologics Llc has filled a SC 13D/A form regarding China Biologic Products, Inc 111.49 -4.62 -3.98% . Filing Link: 000119312515224772.
Form 8-K China Biologic Products, For: Jun 15  StreetInsider.com
New Lifetime High For China Biologic Products (CBPO)
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
China Biologic Products, Inc. (CBPO) Files Form 4 Insider Selling : David Hui ...
China Biologic Products, Inc. (CBPO): David Hui Li , director of China Biologic Products, Inc. sold 2,645,000 shares on Jun 15, 2015.
China Biologic Products, Inc. (NASDAQ:CBPO) Price Target Update  American Trade Journal
Stock in Motion: China Biologic Products, Inc. (NASDAQ:CBPO)  Vanguard Tribune
China Biologic Products, Inc. Analyst Rating Update
Analysts at Zacks have given a short term rating of strong buy on China Biologic Products (NASDAQ:CBPO) with a rank of 1. The company has received an average rating of 1 from 2 brokerage firms. 2 analysts have rated the company as a strong buy. China ...
China Biologic Products, Inc. (NASDAQ:CBPO) Sees Large Inflow of Net Money ...  News Watch International
Moving Stocks: China Biologic Products, Inc. (NASDAQ:CBPO), The Men's ...  StreetWise Report
Earnings in Focus: China Biologic Products, Inc. (NASDAQ:CBPO)
China Biologic Products, Inc. (NASDAQ:CBPO) is expected to post quarterly earnings on 2015-08-04. Investors will be eagerly eyeing the number the company reports compared to the earnings per share that brokers are predicting.
A Chinese Biotechnology Company Gets On The Radar -- And Doubles  Forbes
China Biologic Products, Inc. (CBPO) Discloses Form 4 Insider Selling : Exec ...
China Biologic Products, Inc. (CBPO) Discloses Insider Transaction. David Hui Li , director of China Biologic Products, Inc. sold 2,645,000 shares on Jun 15, 2015. The Insider selling transaction was disclosed on Jun 17, 2015 to the Securities and ...
New Lifetime High Reached By China Biologic Products (CBPO)
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Can The Uptrend Continue for China Biologic Products (CBPO)?
Investors certainly have to be happy with China Biologic Products Inc (CBPO - Snapshot Report) and its short term performance.
Analyst Perspectives on China Biologic Products, Inc. (NASDAQ:CBPO)
Based on analyst estimates, China Biologic Products, Inc. (NASDAQ:CBPO) is expected to post current fiscal quarter earnings per share of $0.84.
China Biologic Products Q4 2014 Earnings: Primed For A Sell-Off? (CBPO)
Before Q2 earnings on August 5, I wrote a bullish article on China Biologic Products (NASDAQ:CBPO), with a thesis stating that the company's plasma-based products should benefit from increasing market demand in China for Q2. I argued that the company's ...